ABBV
48
2
GM
61
4
DTE
54
5
DNB
56
2
PFG
30
3
NWSA
75
8
URI
39
3
DGX
29
2
GPC
35
6
AME
50
3
DAL
64
3
AIV
40
3
RCL
76
3
FOXA
69
5
CHD
37
5
ALLE
25
4
AZO
50
2
FLS
63
2
SYF
83
7
SLB
45
4
ABBV
48
2
GM
61
4
DTE
54
5
DNB
56
2
PFG
30
3
NWSA
75
8
URI
39
3
DGX
29
2
GPC
35
6
AME
50
3
DAL
64
3
AIV
40
3
RCL
76
3
FOXA
69
5
CHD
37
5
ALLE
25
4
AZO
50
2
FLS
63
2
SYF
83
7
SLB
45
4
Financhill
Back

Cryo-Cell International 10K Form

Buy
59

CCEL
Cryo-Cell International

Last Price:
$7.69
Seasonality Move:
-2.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CCEL News And Ratings

See the #1 stock for the next 7 days that we like better than CCEL

CCEL Financial Statistics

Sales & Book Value

Annual Sales: $31.3M
Cash Flow: $-911.8K
Price / Cash Flow: 36.38
Annual Sales: $-1.33
Price / Book: 0

Profitability

EPS (TTM): -1.12080
Net Income (TTM): $-9.3M
Gross Margin: $22.9M
Return on Equity: 0%
Return on Assets: -14.35%

Cryo-Cell International Earnings Forecast

Key Cryo-Cell International Financial Ratios

  • The Gross Profit Margin over the past 28 years for CCEL is 73.07%.
  • The Selling, General & Administrative Expenses for CCEL have been equal to 54.61% of Gross Profit Margin.
  • The Research & Development expenses have been 3.74% of Revenue.
  • The Interest Expense is -12.99% of Operating Income.
  • The Net Earning history of CCEL is -30.38% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 13 years.

Cryo-Cell International Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: CCEL
Website: cryo-cell.com

Debt

Debt-to-Equity Ratio: -1.19
Current Ratio: 0.52
Quick Ratio: 0.43

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 28.7

CCEL Technical Analysis vs Fundamental Analysis

Buy
59
Cryo-Cell International (CCEL) is a Buy

Is Cryo-Cell International a Buy or a Sell?